California State Teachers Retirement System Has $484.72 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
California State Teachers Retirement System Has $484.72 Million Stake in Merck & Co., Inc. $MRK MarketBeat
Merck & Co Company News
Merck & Co Inc's Dividend Analysis - GuruFocus
Merck & Co Inc's Dividend Analysis GuruFocus
Our Q2 2026 financial results - Merck | Home
Our Q2 2026 financial results Merck | Home
Merck eyes expansion of Montgomery County campus amid $2.9B investment - The Business Journals
Merck eyes expansion of Montgomery County campus amid $2.9B investment The Business Journals
Merck trims another 54 jobs in New Jersey amid multiyear cost-cutting initiative - Fierce Pharma
Merck trims another 54 jobs in New Jersey amid multiyear cost-cutting initiative Fierce Pharma
Merck & Co. stock edges higher as analysts hold to cautious targets - ad-hoc-news.de
Merck & Co. stock edges higher as analysts hold to cautious targets ad-hoc-news.de
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - businesswire.com
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference businesswire.com
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges - CNBC
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges CNBC
Merck Ranks No. 9 Nationally as 41 New Jersey Companies Make Forbes Best Employers List - WDHA FM
Merck Ranks No. 9 Nationally as 41 New Jersey Companies Make Forbes Best Employers List WDHA FM
StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too - Genetic Engineering and Biotechnology News
StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too Genetic Engineering and Biotechnology News
Merck & Co., Inc. Target of Unusually Large Options Trading (NYSE:MRK) - MarketBeat
Merck & Co., Inc. Target of Unusually Large Options Trading (NYSE:MRK) MarketBeat
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline - businesswire.com
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline businesswire.com
Our Q4 and full-year 2025 financial results - Merck | Home
Our Q4 and full-year 2025 financial results Merck | Home
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC
Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen MarketBeat
The Manufacturers Life Insurance Company Has $266.40 Million Position in Merck & Co., Inc. $MRK - MarketBeat
The Manufacturers Life Insurance Company Has $266.40 Million Position in Merck & Co., Inc. $MRK MarketBeat
IPG Investment Advisors LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
IPG Investment Advisors LLC Lowers Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Corient Private Wealth LP - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Corient Private Wealth LP MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages MarketBeat
Allworth Financial LP Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Allworth Financial LP Decreases Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says MarketBeat
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $172.00 - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $172.00 MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says MarketBeat
NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.9% - Should You Sell? - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.9% - Should You Sell? MarketBeat
Burford Brothers Inc. Sells 7,962 Shares of Merck & Co., Inc. $MRK - MarketBeat
Burford Brothers Inc. Sells 7,962 Shares of Merck & Co., Inc. $MRK MarketBeat
Baird Financial Group Inc. Sells 98,410 Shares of Merck & Co., Inc. $MRK - MarketBeat
Baird Financial Group Inc. Sells 98,410 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Given New $161.00 Price Target at Leerink Partners - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given New $161.00 Price Target at Leerink Partners MarketBeat
National Pension Service Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
National Pension Service Raises Stake in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Ameritas Advisory Services LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Ameritas Advisory Services LLC MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Groupe la Francaise - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Groupe la Francaise MarketBeat
B. Metzler seel. Sohn & Co. AG Sells 11,777 Shares of Merck & Co., Inc. $MRK - MarketBeat
B. Metzler seel. Sohn & Co. AG Sells 11,777 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck to split cancer, specialty drug businesses in leadership shakeup - BioPharma Dive
Merck to split cancer, specialty drug businesses in leadership shakeup BioPharma Dive
11,499 Shares in Merck & Co., Inc. $MRK Bought by Blue Edge Capital LLC - MarketBeat
11,499 Shares in Merck & Co., Inc. $MRK Bought by Blue Edge Capital LLC MarketBeat
Merck exec says company is discussing use of COVID antiviral drug in Ebola response - Reuters
Merck exec says company is discussing use of COVID antiviral drug in Ebola response Reuters
Can Merck & Company (MRK)’s Stake in Evaxion A/S (EVAX) Validate the Potential of AI-Driven Vaccine Discovery? - Yahoo Finance
Can Merck & Company (MRK)’s Stake in Evaxion A/S (EVAX) Validate the Potential of AI-Driven Vaccine Discovery? Yahoo Finance
Three Seasons Wealth LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Three Seasons Wealth LLC Raises Stake in Merck & Co., Inc. $MRK MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Merck & Co., Inc. $MRK MarketBeat